HighTower Advisors’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
HighTower Advisors's ACLS Position: Q1 2026 in Review
HighTower Advisors increased its Axcelis (ACLS) stake by 81% in Q1 2026, buying an estimated $293K and bringing the position to 7,367 shares worth $686K. The position accounts for ﹤0.01% of the portfolio, ranked #2462.
HighTower Advisors first reported a position in ACLS in Q4 2022 and has held it in 12 quarters since. The position peaked at $773K in Q3 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- HighTower Advisors held 7,367 shares of Axcelis worth $686K as of Q1 2026.
- HighTower Advisors bought 3,306 Axcelis shares in Q1 2026, an estimated $293K.
- Axcelis made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #2462 holding.
- HighTower Advisors first reported a position in Axcelis in Q4 2022 and has held it in 12 quarters since.
- HighTower Advisors's Axcelis position peaked at $773K in Q3 2023.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.